Cancer Family
Mesenchymal Cell Neoplasm
CI-CAN-00000027Explore in graph →
Non-malignant413 active trials10 approved drugs208 evidence items
- NCIt
- C7059
Loading cancer entity…
Cancer Family
CI-CAN-00000027Explore in graph →
Clinical trials
1,848 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02171286 | The Oncopanel Pilot (TOP) Study | completed | — | 432 | British Columbia Cancer AgencyOTHER | 1 | Apr 14, 2017 | clinicaltrials |
| NCT00706810 | Combination of Hydroxyurea and Verapamil for Refractory Meningiomas | completed | Phase 2 | 8 | University of UtahOTHER | 1 | Apr 13, 2017 | clinicaltrials |
| NCT01412489 |
| Intrauterine Adhesion Rate After Hysteroscopic Myomectomy and Application of HYALOBARRIER Gel(HYGEM) |
| completed |
| N/A |
| 189 |
| Assistance Publique - Hôpitaux de ParisOTHER |
| 1 |
| Mar 28, 2017 |
| clinicaltrials |
| NCT01936493 | Biologic Predictors of Leiomyoma Treatment Outcomes | completed | — | 38 | Elizabeth A. StewartOTHER | 1 | Mar 27, 2017 | clinicaltrials |
| NCT01537744 | A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma | completed | Phase 1 | 18 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Mar 24, 2017 | clinicaltrials |
| NCT01588353 | Collagenase Option for Reduction of Dupuytren's Contracture in Japan(CORD-J) | completed | Phase 3 | 104 | Asahi Kasei Therapeutics CorporationINDUSTRY | 1 | Mar 21, 2017 | clinicaltrials |
| NCT01125800 | A Phase I Dose Finding and Safety Study of Oral LDE225 in Children and a Phase II Portion to Assess Preliminary Efficacy in Recurrent or Refractory MB | completed | Phase 1 / Phase 2 | 76 | Novartis PharmaceuticalsINDUSTRY | 6 | Mar 20, 2017 | clinicaltrials |
| NCT00408681 | Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant(GVHD) | completed | N/A | 20 | Fred Hutchinson Cancer CenterOTHER | 1 | Mar 7, 2017 | clinicaltrials |
| NCT01110668 | Evaluation of Nilotinib In Patients With Advanced Gastrointestinal Stromal Tumor (GIST) | completed | Phase 2 | 2 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 28, 2017 | clinicaltrials |
| NCT00171912 | Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes | completed | Phase 2 | 38 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT00718562 | Efficacy and Safety of AMN107 in Patients With GastroIntestinal Stromal Tumors (GIST) Who Have Failed Both Imatinib and Sunitinib | completed | Phase 2 | 35 | Novartis PharmaceuticalsINDUSTRY | 1 | Feb 23, 2017 | clinicaltrials |
| NCT02249052 | Double Blind Study to Evaluate the Efficacy of Collagenase Histolyticum in the Treatment of Lipoma | completed | Phase 2 | 19 | Gerut, Zachary, M.D.INDIV | 1 | Feb 23, 2017 | clinicaltrials |
| NCT01506596 | Study of Pazopanib in the Treatment of Surgically Unresectable or Metastatic Liposarcoma | completed | Phase 2 | 42 | Vector OncologyOTHER | 1 | Feb 15, 2017 | clinicaltrials |
| NCT00815945 | Multicenter Trial With PegLiposomal Doxorubicin and Carboplatin Combination Chemotherapy in Gynecological Sarcomas and Mixed Epithelial-Mesenchymal Tumors | completed | Phase 2 | 41 | AGO Study GroupOTHER | 1 | Feb 14, 2017 | clinicaltrials |
| NCT00592345 | High-Dose Proton/Photon RT + Surgery of Sarcomas of the Thoracic, Lumbar Spine/Sacrum | completed | Phase 1 / Phase 2 | 50 | Massachusetts General HospitalOTHER | 1 | Feb 3, 2017 | clinicaltrials |
| NCT02635789 | Phase III Trial of Topical Formulation of Sirolimus to Skin Lesions in Patients With Tuberous Sclerosis Complex (TSC) | completed | Phase 3 | 62 | NobelpharmaINDUSTRY | 1 | Feb 2, 2017 | clinicaltrials |
| NCT00444795 | Post Marketing Surveillance Study To Observe Safety And Efficacy Of Sutene | completed | — | 520 | PfizerINDUSTRY | 1 | Feb 1, 2017 | clinicaltrials |
| NCT01643278 | Dasatinib and Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumors or Other Sarcomas That Cannot Be Removed by Surgery or Are Metastatic | completed | Phase 1 | 29 | National Cancer Institute (NCI)NIH | 1 | Jan 10, 2017 | clinicaltrials |
| NCT01289028 | Efficacy of Nilotinib in Adult Patients With Gastrointestinal Stromal Tumors Resistant to Imatinib and Sunitinib. | completed | Phase 3 | 125 | Novartis PharmaceuticalsINDUSTRY | 2 | Jan 2, 2017 | clinicaltrials |
| NCT02997787 | New Inflammation Markers for Distinguishing Uterine Adenomyosis and Leiomyoma | completed | — | 60 | Kayseri Education and Research HospitalOTHER_GOV | 0 | Dec 26, 2016 | clinicaltrials |
| NCT02996747 | Low Grade Chondrosarcoma Versus Enchondroma(CONDRO1) | completed | — | 102 | Istituto Ortopedico RizzoliOTHER | 0 | Dec 22, 2016 | clinicaltrials |
| NCT00031629 | Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the Uterus | completed | Phase 2 | 51 | Gynecologic Oncology GroupNETWORK | 1 | Dec 8, 2016 | clinicaltrials |
| NCT02986503 | European Study in Bone Sarcoma Patients Over 40 Years(EUROBOSS) | completed | — | 100 | Italian Sarcoma GroupNETWORK | 3 | Dec 8, 2016 | clinicaltrials |
| NCT02150213 | Medical Safety Follow-up Study for Patients Who Received More Than 28 Days of Total Exposure to BGG492 | completed | Phase 2 | 59 | Novartis PharmaceuticalsINDUSTRY | 6 | Dec 5, 2016 | clinicaltrials |
| NCT01852734 | Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives | completed | N/A | 52 | Odense University HospitalOTHER | 1 | Nov 28, 2016 | clinicaltrials |
| NCT02465814 | Assess Safety and Efficacy of Vilaprisan in Patients With Uterine Fibroids(ASTEROID 2) | completed | Phase 2 | 120 | BayerINDUSTRY | 16 | Nov 22, 2016 | clinicaltrials |
| NCT01483014 | Phase ll Study of Imatinib Mesylate for the Neoadjuvant Treatment of Patients With Gastrointestinal Stromal Tumors (GIST)(CONVERT) | completed | Phase 2 | 30 | Novartis PharmaceuticalsINDUSTRY | 1 | Nov 18, 2016 | clinicaltrials |
| NCT01388907 | Efficacity Assessment of PREVADH® in Adhesion Prevention in Gynaecologic Surgery | completed | Phase 4 | 61 | Medtronic - MITGINDUSTRY | 1 | Nov 17, 2016 | clinicaltrials |
| NCT00897442 | Collecting Tumor Samples From Patients With Gynecological Tumors | completed | — | 275 | Gynecologic Oncology GroupNETWORK | 1 | Oct 28, 2016 | clinicaltrials |
| NCT01613313 | A Dose Escalation Study Using Collagenase Clostridium Histolyticum in the Treatment of Lipoma | completed | Phase 2 | 14 | Zachary GerutINDIV | 1 | Oct 6, 2016 | clinicaltrials |
| NCT01404650 | Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor | completed | Phase 2 | 25 | SCRI Development Innovations, LLCOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT01538017 | Injectable Collagenase and Percutaneous Needle Fasciotomy for Dupuytren's Contracture | completed | N/A | 50 | Jeppe Lange, MDOTHER | 1 | Oct 4, 2016 | clinicaltrials |
| NCT02383901 | A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX(FORTO) | completed | — | 116 | Isofol Medical ABINDUSTRY | 4 | Sep 5, 2016 | clinicaltrials |
| NCT01592903 | Somatic Stem Cells in Leiomyomas? | completed | — | 16 | IgenomixINDUSTRY | 1 | Aug 31, 2016 | clinicaltrials |
| NCT00287846 | Imatinib Mesylate in Treating Patients With Recurrent or Refractory Fibromatosis | completed | Phase 1 / Phase 2 | 40 | UNICANCEROTHER | 1 | Aug 30, 2016 | clinicaltrials |
| NCT01343277 | A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma | completed | Phase 3 | 579 | Janssen Research & Development, LLCINDUSTRY | 4 | Aug 26, 2016 | clinicaltrials |
| NCT02877368 | Sarcopenia in Patients With Gastrointestinal Stromal Tumours(SARCO-GIST) | completed | — | 31 | CHU de ReimsOTHER | 1 | Aug 24, 2016 | clinicaltrials |
| NCT01876498 | Registry of Patient With M. Dupuytren and Validation of the Brief MHQ | completed | — | 60 | Schulthess KlinikOTHER | 1 | Aug 22, 2016 | clinicaltrials |
| NCT02267928 | Information Presentation Formats | completed | N/A | 305 | Carnegie Mellon UniversityOTHER | 1 | Aug 2, 2016 | clinicaltrials |
| NCT02819609 | Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids | completed | — | 12,234 | Quintiles, Inc.INDUSTRY | 0 | Jun 30, 2016 | clinicaltrials |
| NCT00785785 | A Study of Nilotinib Versus Imatinib in GIST Patients(ENESTg1) | completed | Phase 3 | 644 | Novartis PharmaceuticalsINDUSTRY | 35 | Jun 16, 2016 | clinicaltrials |
| NCT01144247 | Cellular Immunotherapy Study for Brain Cancer(alloCTL) | completed | Phase 1 | 10 | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 27, 2016 | clinicaltrials |
| NCT00003590 | S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma | completed | Phase 2 | 29 | SWOG Cancer Research NetworkNETWORK | 1 | May 20, 2016 | clinicaltrials |
| NCT00954473 | Study of Blood Samples From Patients With Osteosarcoma | completed | — | 1,000 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
| NCT01496573 | Biomarkers in Tumor Tissue Samples From Younger Patients With Rhabdomyosarcoma | completed | — | 77 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
| NCT01807052 | Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas | completed | — | 34 | Children's Oncology GroupNETWORK | 1 | May 19, 2016 | clinicaltrials |
| NCT01668095 | Biomarkers in Patients With Advanced Rhabdomyosarcoma | completed | — | 10 | Children's Oncology GroupNETWORK | 1 | May 18, 2016 | clinicaltrials |
| NCT00720174 | Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | May 17, 2016 | clinicaltrials |
| NCT01567046 | Studying Genes in Tissue Samples From Younger and Adolescent Patients With Soft Tissue Sarcomas | completed | — | 70 | Children's Oncology GroupNETWORK | 1 | May 17, 2016 | clinicaltrials |
| NCT01478373 | Efficacy and Safety of Dovitinib in Patients With Gastrointestinal Stromal Tumors Refractory and/or Intolerant to Imatinib | completed | Phase 2 | 39 | Novartis PharmaceuticalsINDUSTRY | 5 | Apr 27, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Apr 14, 2017source: clinicaltrials